Does EMAPALUMAB-LZSG Cause Off label use? 51 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Off label use have been filed in association with EMAPALUMAB-LZSG. This represents 38.6% of all adverse event reports for EMAPALUMAB-LZSG.
51
Reports of Off label use with EMAPALUMAB-LZSG
38.6%
of all EMAPALUMAB-LZSG reports
31
Deaths
20
Hospitalizations
How Dangerous Is Off label use From EMAPALUMAB-LZSG?
Of the 51 reports, 31 (60.8%) resulted in death, 20 (39.2%) required hospitalization, and 8 (15.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMAPALUMAB-LZSG. However, 51 reports have been filed with the FAERS database.
What Other Side Effects Does EMAPALUMAB-LZSG Cause?
Septic shock (19)
Haemophagocytic lymphohistiocytosis (17)
Condition aggravated (16)
Death (13)
Drug ineffective (11)
Pyrexia (8)
Gastrointestinal haemorrhage (7)
Respiratory failure (6)
Seizure (6)
Colitis (5)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which EMAPALUMAB-LZSG Alternatives Have Lower Off label use Risk?
EMAPALUMAB-LZSG vs EMEND
EMAPALUMAB-LZSG vs EMICIZUMAB
EMAPALUMAB-LZSG vs EMICIZUMAB-KXWH
EMAPALUMAB-LZSG vs EMPAGLIFLOZIN
EMAPALUMAB-LZSG vs EMPAGLIFLOZIN\LINAGLIPTIN